Algae and plants
for the earth.Cultivating Algae's Potential,
for a Better Future.



Cultivating Algae's Potential,
for a Better Future.

1.Cultivating Algae's Potential

Our principal mission is to cultivate algae's potential based on our unique capailities built upon our access to approximately 3,000 algae strains. Our unique capabilities with proprietary breeding technology, strain screening capability and culitivation expertise will put us in a unique position unlocking algae's potential for a better future.

Production of Algae

2.Scientific Research for a Better Future

With our principal mission "Cultivating Algae's Potential, for a Better Future", we strive to identify various functional benefits of algae strains. With our endless effort in scientific research, we contribute to build a better solution for food, wellness, beauty and other industries.

Study of “Nanairo chlorella”

Our Business

Joint Research

Feasibility Study

We provide research and technical support to companies which consider leveraging algal-biotechnologies.

Laboratory Analysis

We perform algae-related laboratory analysis such as total starch content, total oil content, fatty acid composition, pigment composition analysis etc.

3D Modelling

We provide 3D stereoscopic construction of electron microscopes and manufacturing of 3D models with a 3D printer.

Cartenoid Analysis by HPLC analysis

Contract Research and Production

Strain Selection

We have capability of strain selection from over 3,000 unique microalgae stratins optiimized for customer needs.

Lab-Scale Extraction

We have capability of extracting targeted functional ingredients based on customer needs.


We have capability of cultivating and producing algae at scale.

Example : Extensive experience in 10L scale cultivation.

Cultivation and Production
Technology Center


We provide joint-market development service to customers who are willing to enter certain market with algae based products.

About Us


Algal Bio Co., Ltd.

We strve to be a leading algae based biotech (algal-bio) platform for a better future.


[Head office]
Tokatsu Techno Plaza 301
5-4-6 Kashiwanoha, Kashiwa,
Chiba 277-0882, Japan
Phone:04-7138-6207 FAX:04-7138-6203
[Office / Laboratory]
Todai-Kashiwa Venture Plaza,
5-4-19 Kashiwanoha, Kashiwa,
Chiba, 277-0882, Japan

Cultivation and
Production Technology
We have built Cultivation and Production Technology Center nearby Funado, Kashiwa to begin mass cultivation in April. 2019.
March 1, 2018
Founder & CEO
Tsuyoshi Takeshita
Key Investors
The University of Tokyo Edge Capital Partners Co., Ltd. (UTEC)
Japan Science and Technology Agency (JST)
Abies Ventures, Inc.
Kyoto University Innovation Capital Co., Ltd.
Chiba Bank Capital Co., Ltd.
Japan Material Technologies Corporation

Leadership Team

Founder & CEO / Tsuyoshi Takeshita
Tsuyoshi founded Algal Bio in March 2018. Before founding Algal Bio, Tsuyoshi worked as a special researcher at the Department of Advanced Biosciences at the University of Tokyo. He earned Ph.D. in Life Sciences from the Graduate School of Frontier Sciences at the University of Tokyo.

Board of Directors

Director / Keisuke Ide
[Career] Keisuke is a partner at UTEC (The University of Tokyo Edge Capital Partners) and joined our board in Dec. 2018. At UTEC, he focuses on innovative technologies as well as IT-enabled solutions. He spent 15 years in the US, half of which in Silicon Valley. He currently sits on the boards of Nelumbo Inc, BionicM, Seaos, and Routrek Networks. He was the lead investor and served as board director for AI inside (IPO), GLM Inc. (M&A), IID (IPO), and played an instrumental role for Phyzios’ M&A exit to Google Inc.
Auditor / Junya Yamazaki
[Career] Junya is a principal at UTEC and appointed as an auditor of Algal Bio in May 2020. He mainly focuses on seed/early stage investments in life science and healthcare at UTEC. Prior to UTEC, he worked at Takeda Pharmaceutical (Osaka and Cambridge, MA), where he conducted financial evaluation, commercial assessment, and financial / portfolio management for R&D assets. He also supported in-licensing deals from financial and clinical perspectives. Previously, he was an equity analyst at Goldman Sachs and Jefferies, and covered Japanese Pharmaceutical industry.

Our Journey

April, 2011
A research group led by Professor Shigeyuki Kono was selected by the Japan Science and Technology Agency (JST) for the “2010 Core Research for Evolutional Science and Technology (CREST)” program, and Tsuyoshi, our Founder & CEO, took part in the research of "technological advances in producing strains for biofuel through micro algae multiplication and heavy ion beam irradiation.
September, 2015
Tsuyoshi, our Founder & CEO, was selected by the Japan Science and Technology Agency’s (JST) Program for Creating Start-ups from Advanced Research and Technology (START) program with his research on “technology for mass cultivation of multi-colored carotenoids and long-chain unsaturated fatty acids derived from chlorella.”
July, 2016
Tsuyoshi, our Founder & CEO, was selected for the KAKEHASHI "Bridge" Project, a program to promote research exploration and collaboration within the Tsukuba Innovation Arena (TIA). He devoted himself to this program through a research project such as "functional testing of over 3000 algae bio-strains and development of new markets in the age of self-medication" etc.
April, 2017
The Future Center Initiative was launched by the University of Tokyo, and Tsuyoshi moved its research base to the current headquarter, Tokatsu Techno Plaza.
March 1, 2018
Algal Bio Co.,Ltd. was established.
October, 2018
Opened a new research center in the Todai-Kashiwa Venture Plaza.
April, 2019
Our Cultivation and Production Technology Center in Kashiwa started its operation.


Postdoctorial Researcher

Contact Us

Please fill in following format for any inquiry.
Fields marked with an asterisk (*) are required.